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Abstract: Full completion of cognitive screening tests can be problematic in the context of a stroke.
Our aim was to examine the completion of various brief cognitive screens and explore reasons for
untestability. Data were collected from consecutive stroke admissions (May 2016–August 2018).
The cognitive assessment was attempted during the first week of admission. Patients were classified
as partially untestable (≥1 test item was incomplete) and fully untestable (where assessment was not
attempted, and/or no questions answered). We assessed univariate and multivariate associations
of test completion with: age (years), sex, stroke severity (National Institutes of Health Stroke Scale
(NIHSS)), stroke classification, pre-morbid disability (modified Rankin Scale (mRS)), previous stroke
and previous dementia diagnosis. Of 703 patients admitted (mean age: 69.4), 119 (17%) were
classified as fully untestable and 58 (8%) were partially untestable. The 4A-test had 100% completion
and the clock-draw task had the lowest completion (533/703, 76%). Independent associations with
fully untestable status had a higher NIHSS score (odds ratio (OR): 1.18, 95% CI: 1.11–1.26), higher
pre-morbid mRS (OR: 1.28, 95% CI: 1.02–1.60) and pre-stroke dementia (OR: 3.35, 95% CI: 1.53–7.32).
Overall, a quarter of patients were classified as untestable on the cognitive assessment, with test
incompletion related to stroke and non-stroke factors. Clinicians and researchers would benefit from
guidance on how to make the best use of incomplete test data.
Keywords: feasibility; cognitive screening instruments; cognition; stroke
1. Introduction
Cognitive screening following a stroke is recommended in international clinical guidelines [1,2]
and routinely performed in acute stroke settings in many countries. However, completion of a cognitive
test battery in a medically unwell person with recent neurological insult is challenging. Previous
research has demonstrated that around 20% of stroke patients cannot fully complete many of the
cognitive screening tests commonly used in stroke practice, for example the Montreal Cognitive
Assessment (MoCA) [3] and the Mini-Mental State Examination (MMSE) [4]. Test non-completion is
reported in both acute stroke [5] and rehabilitation settings [6] (Table 1). However, published data
appear conflicting and other centres have reported that a lengthy neuropsychological battery can be
performed in the acute setting [7].
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Table 1. Previous studies addressing feasibility of cognitive assessments post-stroke.
Study Test Number ofPatients
Inclusion Criteria
Relevant to Feasibility Time Point Completion Rate
Setting: Acute
Alderman et al.
[8] (CA)
Battery of 8
tests 27 Mild strokes and TIAs ≤24 h 96%
Collas 2016 [9]
(CA) OCS 155 No relevant exclusions 5 days (mean) 89%
Horstmann et al.
[10] MoCA 842
IS and ICH. No relevant
exclusions
2 days
(median) 81%
Pasi et al. [5] MoCA 137 IS and ICH. No relevantexclusions 5–9 days 83%
Pendlebury et al.
[11]
AMT
MMSE 1097 No relevant exclusions
4 days
(median)
76% partially testable
69% fully testable
Van Zandvoort
et al. [7] 1.5-h NPB 57
IS only, no previous
stroke, maximum age 80,
mRS 2–4, no psychiatric
history or comorbidity
that could influence
cognitive functioning
4–22 days 75%
Setting: Sub-Acute/Rehabilitation
Barnay et al. [12]
CASP
MMSE
MoCA
44 All aphasic patients 42 ± 22 days
CASP 82%
MMSE 64%
MoCA 70%
Benaim et al. [6]
CASP
MMSE
MoCA
50 Non-aphasic patientsonly 40 ± 17 days
CASP 100%
MMSE 100%
MoCA 94%
Cumming et al.
[13] MoCA 220
IS and ICH. No relevant
exclusions 3 months
Mild stroke 87%
Moderate stroke 79%
Severe stroke 67%
Kwa et al. [14] CAMCOG 129 IS only ≥3 months 88%
Mancuso et al.
[15]
OCS
MMSE 325
No previous stroke, able
to consent themselves,
no previous
psychiatric/neurological
disease
33.9 ± 41.8 days
Fully untestable:
MMSE 2%, OCS 1%
Highest incompletion
for individual OCS
tasks: trails
28/325 (9%)
Lees et al. [16]
ACE-III
MMSE
MoCA
51 No relevant exclusions 36 days(median)
ACE-III 27%
MMSE 43%
MoCA 39%
Abbreviations: Abbreviated Mental Test (AMT); Addenbrooke’s Cognitive Examination III (ACE-III); Cambridge
Cognition Examination (CAMCOG); Cognitive assessment scale for stroke patients (CASP); conference abstract (CA);
ischaemic stroke (IS); intracerebral haemorrhage (ICH); Mini-Mental State Examination (MMSE); Montreal Cognitive
Assessment (MoCA); neuropsychological battery (NPB); Oxford Cognitive Screen (OCS); transient ischaemic attack
(TIA); modified Rankin Scale (mRS).
Feasibility of completing a cognitive assessment is multifactorial; some aspects may relate to the
stroke (extent of damage, presence of aphasia, limb weakness) and others may relate to the nature of
the testing (timing and length of assessment, complexity). Looking at the patient characteristics and
approaches to assessment can explain the apparently contradictory findings in the literature. Patients
included in studies of cognitive tests are often not representative of a typical stroke unit. For example,
studies may favour the inclusion of those with minor strokes, no (or little) pre-stroke disability and
those who are able to provide informed consent, whilst patients with severe aphasia or an existing
diagnosis of dementia are often excluded [17]. This selection bias will underestimate the true incidence
of untestable patients.
An incomplete cognitive test has clinical implications. Inexperienced assessors may erroneously
ascribe an incomplete test to cognitive impairment, when in the context of stroke, non-completion
may relate to physical impairments. Ultimately, test non-completion could risk false positive and
false negative diagnosis of cognitive problems with attendant harm. An understanding of the extent
of test non-completion and knowledge of factors relating to untestability could potentially avoid
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this. The issue of test incompletion also complicates stroke research and audit. Often patients with
incomplete assessments are excluded from analyses (since a total score cannot be calculated). This
practice biases results, underestimates levels of cognitive impairment and could also lead to erroneous
results [11]. Various approaches to incorporate incomplete tests have been proposed but there is no
consensus on the best method [16].
There are different ways to address these feasibility issues, but the approach taken will depend on
the aspect of feasibility of greatest relevance. For example, one may decide to choose a test specifically
designed for a stroke (e.g., Oxford Cognitive Screen (OCS) [18]). This approach recognises that many
traditional cognitive tests were designed for memory clinic populations and are not suited to the specific
challenges encountered in acute stroke settings. Stroke specific, multi-domain tests are described and
may be less biased by physical, communication and visuospatial impairments. Another approach may
be to choose a shorter cognitive screen. This approach may be particularly suited to the acute medical
setting where clinicians have limited time and other investigations may be prioritised in the first few
days. Shorter tests may also be attractive to patients as there will be a reduced test burden. Short
cognitive screens have been largely ignored in research conducted in the stroke setting. Stroke care is
continuously evolving and differs internationally, but there is currently a paucity of feasibility research
on cognitive tests in an acute, National Health Service (NHS) context. Our research aimed to meet
these two gaps.
Our primary aim was to describe the test completion (feasibility) of some of the shortest cognitive
screens (deliverable in under five min) in an unselected group admitted to our hyper-acute stroke unit.
Our secondary aims were to explore reasons for assessors giving a patient a label of being untestable
and to describe factors associated with being untestable.
2. Methods
We conducted an observational, cross-sectional study, using routinely collected data from an
urban UK, teaching hospital. This was approved by the West of Scotland Research Ethics Committee
(ws/16/0001) on 4 February 2016. We followed Standards of Reporting of Neurological Disorders
(STROND) guidance [19] for the design, conduct and reporting of the study.
2.1. Setting and Population
We collected anonymised, routine, clinical data from consecutive admissions to our hyper-acute
stroke unit (HASU). The unit admits all suspected stroke and transient ischaemic attack (TIA) patients
with no exclusions in relation to age, disability or comorbidity. The unit offers level two (high
dependency) clinical care and only patients requiring multi-organ support would be admitted to a
higher-level care facility. Recruitment occurred during four timepoints: May 2016–February 2017;
April–June 2017; October–December 2017; and July–August 2018. For the purposes of this study,
we made no exclusions around stroke severity or stroke-related impairments. Written informed consent
was not required for assessment.
2.2. Clinical and Demographic Assessment
Clinical and demographic data were collected for each patient by five trained researchers
(four postgraduate students in psychology/neuroscience and one undergraduate medical student).
Data collected were a mix of prospective assessment and retrospective derivation from medical case
notes. Stroke severity was determined by the National Institutes of Health Stroke Scale (NIHSS) [20]
on admission. Medical history, including any pre-stroke diagnosis of dementia, was recorded using
medical notes and primary care summary data. Pre-stroke functioning was established using the
modified Rankin Scale (mRS) [21–23]. Bamford stroke classification was completed for both ischaemic
and haemorrhagic patients.
2.3. Cognitive Assessment
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The cognitive assessment consisted of 13 questions, covering 8 different cognitive screening tests:
the 10-point Abbreviated mental test score (AMTS) [24] and its shorter version AMT-4 [25], General
Practitioner Assessment of Cognition (GPCOG) (patient section) [26], Mini-Cog [27], six item cognitive
impairment test (6-CIT) [28], National Institute Neurological Disorders S-Canadian Stroke Network
(NINDS-CSN) 5-min MoCA [29], abbreviated MoCA [30], and the 4 ‘A’s Test (4AT) (Available online:
www.the4AT.com) (Table 2). Each of these individual tests can be administered in under 5 min (and so
suitable for use in acute clinical practice). They cover a variety of cognitive domains and have some
supporting validation work in primary and geriatric care [31].
Table 2. Short cognitive tests ordered by number of items.
Test Name Numberof Items Questions
Maximum
Score
% of Assessments We
Could Score in Full
Mini-Cog [27] 2 1 3-word delayed recall
2 Clock draw (numbers, hands)
5 75%
Abbreviated MoCA
[30] 2
1 5-word delayed recall
2 Clock draw (face, numbers, hands)
8 75%
4-AMT [25] 4
1 Age
2 Year
3 Place
4 Date of birth
4 81%
4AT (Available online:
www.the4AT.com) 5
1 Alertness
2 Age
3 Current year
4 Place
5 Date of birth
6 Months backwards
12 100%
6-CIT [28] 6
1 Time
2 Month
3 Yearl
4 Count backwards from 20
5 5-part delayed recall
6 Months backwards
28 78%
GPCOG [26] 7
1 Date
2 Month
3 Year
4 Date of birth
5 5-part delayed recall
6 Clock draw (numbers, hands)
7 News item
9 75%
NINDS-CSN 5 min
MoCA [29] 7
1 Date
2 Month
3 Year
4 Day
5 Place
6 City
7 5-word delayed recall
8 Fluency (letter F)
12 79%
10-AMT [24] 10
1 Age
2 Time
3 Year
4 Place
5 Two-person recognition
6 Date of birth
7 Year of WW1
8 Current prime minister
9 Count backwards from 20
10 3-part delayed recall
10 79%
Abbreviations: Abbreviated mental test (AMT); General Practitioner Assessment of Cognition (GPCOG); Montreal
Cognitive Assessment (MoCA); National Institute of Neurological disorders and stroke and the Canadian stroke
network (NINDS-CSN); Six item cognitive impairment test (6-CIT).
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Assessment was attempted during the first week of admission. Patients were only approached
once for assessment, unless the patient requested for the assessment to be done at a later time-point,
the assessment was interrupted by another clinical investigation (e.g., scan) or if the patient requested
the assessment to be done over two sessions. Patients were not approached at all (and categorised fully
untestable) if the parent clinical team reported that the patient was too unwell to undergo assessment
or if the assessor felt that any form of direct testing would not be possible. In these patients, who could
not be directly assessed, we checked if a cognitive assessment was documented by the parent clinical
team since admission.
2.4. Defining the Test Completion Outcomes
Patients were classified as fully untestable when no part of the assessment was attempted (decision
made by researcher in consultation with parent clinical team) and/or when no questions were answered
when testing was attempted. Partially untestable was defined when at least one item in a test could not
be completed or was not attempted (decided by either the patient, parent clinical team or researcher).
A list of potential categories was created by the authors based on clinical experience, previous literature
and initial scoping of free text responses. The free text reasons documented for each patient classified
as untestable by the individual assessor were later collated into categories (e.g., aphasia and dysarthria
both captured under speech problems) by the lead author (E.Elliott) with discussion with the stroke
consultant (T.Quinn). Where more than one reason was listed, we chose the primary factor deemed
to have the greatest impact on assessment (e.g., a patient documented as both acutely confused and
dysarthric was categorised under confusion). Cases where a test item was attempted but poorly
completed, for example, a patient with limb weakness who attempted the clock-draw with their weak
or non-dominant hand, were classed as testable.
2.5. Statistical Analysis
We described patients as fully or partially untestable using the definitions above. We looked at
the completion rate of each question in our assessment and then calculated completion rates for the
different tests. Patients who ended up with a non-stroke diagnosis were kept in the analyses as we
were interested in the feasibility of tests within all patients admitted with a suspected stroke and we
retained admission NIHSS for these patients where it was completed.
We assessed univariable and multivariable associations with outcomes of interest using logistic
regression. Variables were chosen based on previous literature [10,11] and plausible associations
with feasibility. The following 12 covariates were used in both univariate and multivariate analyses:
age (years), sex, NIHSS, Bamford stroke classification (TIA, partial anterior circulation stroke—PACS,
total anterior circulation stroke—TACS, posterior circulation stroke—POCS, lacunar stroke—LACS,
non-stroke (used as reference group)), pre-morbid mRS, presence of intracerebral haemorrhage (ICH),
previous diagnosis of dementia and previous TIA/stroke. We did not include delirium in the model
since our only measure was the 4AT scale and all untestable patients would have ended up with a
label of delirium. Associations were described as odds ratios (OR) with corresponding 95% confidence
intervals. We used the rule of 10 outcome events per predictor variable to determine the number of
covariates we could include in the model and so required 120 “cases” for the model.
Analyses were run twice to account for how partially untestable patients are treated differently in
the literature; in the first analysis they were treated as testable and in the second treated as untestable
(grouped with the fully untestable patients). All data analyses were performed using the statistical
software package SPSS (version 25 IBM, Armonk, NY, USA).
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3. Results
The full sample included 703 patients (mean age 69.4 ± 13.7, 382 (54%) males, median NIHSS
2 (interquartile range, IQR 1–5)) (Table 3 for full patient characteristics). Of these, 119 (17%) were
classified as fully untestable on all tests. Reasons for fully untestable fell under eight categories but
for more than half of the group this was due to neurological deterioration (e.g., patients who were
unresponsive, very unwell, palliative) (62/119, 54%). A further 58 (8%) patients in the full sample
were separately classified as partially untestable (did not attempt ≥1 question); reasons fell under
nine categories, with limb weakness 15 (26%) and speech problems 13 (22%) being most prevalent
(full breakdown of reasons detailed in Figure 1). A large proportion of patients in the fully untestable
group (n = 50, 42%) had a TACS, compared to only 3 (5%) in the partially untestable group.
Table 3. Characteristics of the sample.
Characteristics Full Sample(n = 703)
Partially
Untestable (n = 58)
Fully Untestable
(n = 119)
Sex (male) 382 (54%) 27 (47%) 59 (50%)
Age mean (SD) 69.4 (13.7)Missing data (n = 2) 76.6 (9.7)
76.8 (12.5)
Missing data (n = 2)
IS
ICH
TIA
Non-stroke
429 IS
22 ICH
137 TIA
109 N/S
Missing data (n = 6)
42 IS
4 ICH
5 TIA
7 N/S
85 IS
8 ICH
11 TIA
13 N/S
Missing data (n = 2)
Bamford classification (IS and ICH)
66 TACS
174 PACS
100 POCS
111 LACS
Missing data (n = 6)
3 TACS
25 PACS
12 POCS
6 LACS
50 TACS
31 PACS
8 POCS
4 LACS
Missing data (n = 2)
NIHSS median (IQR) 2 (1–5)Missing data (n = 15)
4 (3–7)
Missing data (n = 1)
8 (4–16)
Missing data (n = 2)
Pre-morbid mRS median (IQR) 1 (0–3)Missing data (n = 5) 2 (0–3)
3 (0–3)
Missing data (n = 1)
Previous stroke (IS/ICH) or TIA (yes) 218 (31%) 20 (34%) 36 (30%)
Previous diagnosis of dementia (yes) 61 (9%) 8 (14%) 30 (25%)
Abbreviations: ischaemic stroke (IS); interquartile range (IQR); intracerebral haemorrhage (ICH); lacunar stroke
(LACS); modified Rankin Scale (mRS); National Institute for Health Stroke Scale (NIHSS); non-stroke (N/S); partial
anterior circulation stroke (PACS); posterior circulation stroke (POCS); transient ischaemic attack (TIA); total anterior
circulation stroke (TACS).
Patients who ended up with a non-stroke diagnosis (n = 109) were a diverse group (diagnoses
included migraine, subarachnoid haemorrhage and vasovagal events). Of these, 20 (18%) were
untestable in some way. Only 12 patients (2%) of the full sample declined the cognitive assessment;
three declined the full assessment and nine declined certain questions. Characteristics: 7 (58%) males,
mean age of 74.3 (SD = 13.9), median NIHSS of 3 (IQR 2–5), diagnoses: 1 non-stroke, 3 TIAs, 3 PACS,
3 POCS and 2 LACS.
We looked at the completion of each individual question within our full cognitive assessment
(Table S1). Clock-draw had the lowest completion rate (533/703 (76%)), whilst age had the highest
(583/703 (83%)). For 25/58 (43%) patients in the partially untestable group, clock-draw was the only
task that they did not attempt. The completion rate of each individual test is given in Table 2; the 4AT
was the only test which could be scored in full for all patients.
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In the univariate analyses: higher age, TACS, ICH, higher NIHSS, higher pre-morbid mRS and
a previous diagnosis of dementia were associated with being untestable, whilst a lacunar stroke
was associated with being testable (Table 4). In the first multivariable regression analysis (n = 680),
independent associations with fully untestable status were: higher NIHSS score (OR: 1.18, 95% CI:
1.11–1.26), higher pre-morbid mRS (OR: 1.28, 95% CI: 1.02–1.60) and pre-stroke dementia (OR: 3.35,
95% CI: 1.53–7.32). A lacunar stroke classification was associated with being testable (OR: 0.19, 95% CI:
0.06–0.65). In the second analysis (where the partially untestable group was combined with the fully
untestable), the above variables remained significant. In addition, the following associations were
found for being untestable: older age (OR: 1.04, 95% CI: 1.02–1.06) and presence of ICH (OR: 3.44,
95% CI: 1.13–10.44); whilst a TIA classification was associated with being testable (OR: 0.45, 95% CI:
0.20–0.997) (Table 4).
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Table 4. Feasibility associations.
Variables Univariate forFully Untestable
Multivariate (Partially
Treated as Testable)
Multivariate (Partially
Treated as Untestable)
OR (95% CI) OR (95% CI) OR (95% CI)
Age (years) 1.06 (1.04–1.08) 1.02 (1.00–1.04) 1.04 (1.02–1.06)
Sex (male) 0.80 (0.54–1.18) 1.32 (0.77–2.26) 0.97 (0.62–1.51)
Stroke classification (non-stroke used as reference group):
TACS 23.08(10.29–51.76) 2.96 (0.98–8.93) 1.47 (0.50–4.34)
PACS 1.60 (0.80–3.22) 0.73 (0.32–1.65) 0.92 (0.46–1.83)
LACS 0.28 (0.08–0.88) 0.19 (0.06–0.65) 0.26 (0.10–0.64)
POCS 0.64 (0.25–1.62) 0.39 (0.14–1.12) 0.73 (0.33–1.61)
TIA 0.65 (0.28–1.50) 0.55 (0.21–1.40) 0.45 (0.20–1.00 *)
ICH 2.96 (1.21–7.23) 2.48 (0.72–8.59) 3.44 (1.13–10.44)
NIHSS 1.30 (1.23–1.36) 1.18 (1.11–1.26) 1.23 (1.14–1.31)
Pre-morbid mRS 1.64 (1.41–1.91) 1.28 (1.02–1.60) 1.24 (1.03–1.50)
Pre-stroke diagnosis of dementia 6.01 (3.47–10.42) 3.35 (1.53–7.32) 2.74 (1.32–5.70)
Previous stroke (IS, ICH) or TIA 0.96 (0.62–1.47) 0.82 (0.45–1.48) 0.91 (0.56–1.49)
* 0.997. Bold: significant associations. Abbreviations: intracerebral haemorrhage (ICH); ischaemic stroke (IS);
lacunar stroke (LACS); modified Rankin Scale (mRS); National Institute for Health Stroke Scale (NIHSS); partial
anterior circulation stroke (PACS); posterior circulation stroke (POCS); total anterior circulation stroke (TACS);
transient ischemic attack (TIA).
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4. Discussion
In an unselected sample of 703 patients admitted to our HASU, a quarter were classified as
partially or fully untestable on brief cognitive screening tests. In those patients classified as partially
untestable, the clock-draw was the most problematic, so tests including this item had the lowest
completion rate. The 4AT was the only test which could be scored in full for all patients as it includes
a score for being untestable. Factors associated with being fully untestable were previous diagnosis
of dementia, higher pre-morbid mRS and higher NIHSS on admission, whilst a diagnosis of lacunar
stroke was associated with being testable.
4.1. Research in Context
Our findings are generally in keeping with the limited literature on test feasibility. The associations
of non-completion with stroke severity and dementia have face validity and the reasons given for a label
of untestable were similar to those described in previous studies (for example limb weakness [5,11,16],
aphasia [5,10,11], pre-morbid functional status [5] and reduced consciousness [11]), although reporting
reasons for cognitive test non-completion in research is the exception rather than the norm. These
findings highlight that non-completion is driven by both stroke specific and non-stroke related factors.
Our finding that the clock-draw was the most problematic test is also in keeping with previous research
findings for a stroke population; Lees et al. [16] found the lowest rates of completion on test items
that required copying or drawing. Although tasks which assess visuospatial abilities, such as the
clock-drawing test, can be challenging for stroke patients, they provide useful information on a key
cognitive domain and can predict longer-term outcomes [32].
We decided to focus on the shortest cognitive tests available, in the hopes that they would be more
practical for both the patient and clinician. Our results showed that the rates of completion for these
short tests were similar to the completion rates for longer multi-domain cognitive tests previously
studied (MoCA, MMSE). This should not be interpreted as meaning that the shortest tests are just as
likely to be incomplete as more detailed tests. We did not include or directly compare longer tests
with our short screens and our unselected population is not comparable with the patients tested in
previous studies. There is a concern that shorter cognitive tests are inferior to longer, more detailed
tests. Previous work has suggested that there is a trade-off between duration of administration and
diagnostic accuracy [33] in the context of dementia. A focus on length of assessment alone (number of
questions, administration time) is perhaps too simplistic, and test content is likely to be more important.
For example, a long test could assess one area of cognition in depth yet neglect other domains.
4.2. Strengths and Weaknesses of the Research
A major strength of our study is that we had access to an unbiased, real-world sample, including
patients who are often excluded from research (for example those with severe aphasia and dementia).
While using clinical data have these benefits, we also have to acknowledge that due to the ‘messy
reality’ of acute clinical practice, data are often missing. Our approach allowed us to retrospectively
derive missing data from various sources including inpatient medical records, primary care data
and consultation with the parent clinical team. Retrospective scoring can increase some inaccuracy,
for example, calculating NIHSS based on the symptoms documented in medical case notes, rather than
carrying it out directly with the patient.
There were some potentially interesting aspects of feasibility/applicability where we did not
record data. We did not record the total number of patients who had limb weakness from their stroke
and attempted the clock-draw using their weak or non-dominant hand (classed as testable). Data on
this subgroup would be useful as many will lose points or score zero for poorly completed drawing
tasks. We also did not record if an assessment had to be completed over two sessions or if any part of
the assessment was interrupted.
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Although we operationalised our concept of partially and fully untestable there is still subjectivity
in the interpretation. It is essentially a judgement call by the clinician whether patients with aphasia,
limb weakness and visual problems can complete a task (if the patient does not decline themselves).
The same patient could therefore be classified differently purely based on who assessed them. This is
particularly relevant in our study, where differing assessors performed the cognitive testing. This could
be considered both a strength and weakness as it provides further real-world validity (some people
might be better at encouraging patients to complete an assessment than others).
Finally, a limitation of determining feasibility of different questions and their resulting tests is the
order in which the questions are asked. We acknowledge asking questions in the same order for each
patient introduces some bias and is an issue because some patients will struggle to focus for longer
periods of time or are easily fatigued.
4.3. Recommendations for Future Research and Practice
The strict administration and scoring criteria required for cognitive tests can be problematic for
the stroke setting. Clinicians and researchers can therefore expect to encounter a number of stroke
patients that will be untestable on certain tasks, or patients who are testable, but their stroke-related
impairments result in a misleading test score. While in clinical practice an assessment can be put
into context, in research it is more important that a-priori rules are set for dealing with incomplete
tests. The importance of doing this is highlighted by the fact our analyses showed different results
depending on how partially untestable patients were classified. Numerous approaches exist to deal
with missing data [16], but to maximise the utility of the data collected, we recommend, where possible,
that researchers make full use of incomplete participant data, rather than applying a complete-case
analysis approach.
Tests which incorporate scoring for untestable patients, such as the 4AT, are helpful. Although
the 4AT is primarily a delirium screen, the same approach could be applied to general cognitive tests.
Guidance documents exist for scoring other stroke scales such as the NIHSS in patients who are
comatose, confused, etc., so these types of resources could be made available for challenging cases in
cognitive assessment.
Test completion rates are just one measure of feasibility. Feasibility covers a range of factors
relating to the patient, assessor and the ward setting (Figure 2), so future research studies should
include data addressing these other perspectives. To date, there has been little data published on
the clinician’s experience of cognitive assessment, environmental factors affecting assessment on the
ward (noise, space, interruptions) and practical aspects, such as how assessors have misinterpreted
administration/scoring instructions. With the increased use of computerised versions of cognitive tests
in the future, feasibility issues from the assessor’s side are likely to improve; for example, automatic
scoring saves time and reduces scoring errors and subjectivity. Future research should also make
use of routinely collected clinical data, such as that collected by the Sentinel Stroke National Audit
Programme (SSNAP) and the Scottish stroke care audit in the United Kingdom. One could argue that
any study using a researcher to administer a scale, rather than a clinical member of staff, is not truly
addressing broader feasibility and implementation issues.
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